Daewon Pharmaceutical Dividends and Buybacks
Dividend criteria checks 3/6
Daewon Pharmaceutical is a dividend paying company with a current yield of 2.07% that is well covered by earnings. Next payment date is on 21st April, 2025 with an ex-dividend date of 27th December, 2024.
Key information
2.1%
Dividend yield
-0.03%
Buyback Yield
| Total Shareholder Yield | 2.0% |
| Future Dividend Yield | 2.1% |
| Dividend Growth | 9.6% |
| Next dividend pay date | 21 Apr 25 |
| Ex dividend date | 27 Dec 24 |
| Dividend per share | ₩300.000 |
| Payout ratio | 40% |
Recent dividend and buyback updates
Recent updates
Daewon Pharmaceutical Co., Ltd.'s (KRX:003220) P/E Still Appears To Be Reasonable
Jan 06
Daewon Pharmaceutical's (KRX:003220) Conservative Accounting Might Explain Soft Earnings
Nov 22Does Daewon Pharmaceutical (KRX:003220) Have A Healthy Balance Sheet?
Aug 13Daewon Pharmaceutical Co., Ltd.'s (KRX:003220) 27% Jump Shows Its Popularity With Investors
Jul 17There May Be Reason For Hope In Daewon Pharmaceutical's (KRX:003220) Disappointing Earnings
Mar 21Does Daewon Pharmaceutical (KRX:003220) Have A Healthy Balance Sheet?
Mar 26Is Daewon Pharmaceutical Co., Ltd. (KRX:003220) A Smart Pick For Income Investors?
Mar 07Do Insiders Own Lots Of Shares In Daewon Pharmaceutical Co., Ltd. (KRX:003220)?
Feb 18Daewon Pharmaceutical Co., Ltd.'s (KRX:003220) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Jan 31
Did You Miss Daewon Pharmaceutical's (KRX:003220) 26% Share Price Gain?
Jan 13Here's What We Like About Daewon Pharmaceutical's (KRX:003220) Upcoming Dividend
Dec 24Daewon Pharmaceutical (KRX:003220) Seems To Use Debt Quite Sensibly
Dec 10Does Daewon Pharmaceutical Co., Ltd. (KRX:003220) Have A Place In Your Dividend Portfolio?
Nov 22Stability and Growth of Payments
Fetching dividends data
Stable Dividend: A003220's dividend payments have been volatile in the past 10 years.
Growing Dividend: A003220's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Daewon Pharmaceutical Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (A003220) | 2.1% |
| Market Bottom 25% (KR) | 1.2% |
| Market Top 25% (KR) | 3.9% |
| Industry Average (Pharmaceuticals) | 1.1% |
| Analyst forecast (A003220) (up to 3 years) | 2.1% |
Notable Dividend: A003220's dividend (2.07%) is higher than the bottom 25% of dividend payers in the KR market (1.18%).
High Dividend: A003220's dividend (2.07%) is low compared to the top 25% of dividend payers in the KR market (3.9%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (39.7%), A003220's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: A003220 is paying a dividend but the company has no free cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/22 01:32 |
| End of Day Share Price | 2025/01/22 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Daewon Pharmaceutical Co., Ltd. is covered by 11 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jisoo Lee | DAOL Investment & Securities Co., Ltd. |
| Jae Hoon Shin | Hanwha Investment & Securities Co., Ltd. |
| Changhee Woo | IBK Securities Co. Ltd. |